These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 25743093)
1. Growth and gene expression differ over time in alpha-linolenic acid treated breast cancer cells. Wiggins AK; Mason JK; Thompson LU Exp Cell Res; 2015 Apr; 333(1):147-54. PubMed ID: 25743093 [TBL] [Abstract][Full Text] [Related]
2. α-Linolenic Acid Reduces Growth of Both Triple Negative and Luminal Breast Cancer Cells in High and Low Estrogen Environments. Wiggins AK; Kharotia S; Mason JK; Thompson LU Nutr Cancer; 2015; 67(6):1001-9. PubMed ID: 26134471 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231. Rwigemera A; Mamelona J; Martin LJ Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1. Hu M; Wang J; Chen P; Reilly RM Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139 [TBL] [Abstract][Full Text] [Related]
5. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577 [TBL] [Abstract][Full Text] [Related]
6. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
7. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409 [TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Liu Q; Loo WT; Sze SC; Tong Y Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420 [TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115 [TBL] [Abstract][Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
11. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Swami S; Raghavachari N; Muller UR; Bao YP; Feldman D Breast Cancer Res Treat; 2003 Jul; 80(1):49-62. PubMed ID: 12889598 [TBL] [Abstract][Full Text] [Related]
13. PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines. Liu ZB; Hou YF; ; Di GH; Wu J; Shen ZZ; Shao ZM J Cell Biochem; 2009 Sep; 108(1):195-206. PubMed ID: 19562667 [TBL] [Abstract][Full Text] [Related]
14. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Kim JB; Lee KM; Ko E; Han W; Lee JE; Shin I; Bae JY; Kim S; Noh DY Planta Med; 2008 Jan; 74(1):39-42. PubMed ID: 18203057 [TBL] [Abstract][Full Text] [Related]
15. AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib. Maiello MR; D'Alessio A; De Luca A; Carotenuto A; Rachiglio AM; Napolitano M; Cito L; Guzzo A; Normanno N Breast Cancer Res Treat; 2007 May; 102(3):275-82. PubMed ID: 17004112 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231. Gao Y; Ge Z; Zhang Z; Bai Z; Ma X; Wang Y Chin Med J (Engl); 2014; 127(10):1947-53. PubMed ID: 24824261 [TBL] [Abstract][Full Text] [Related]
17. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
18. Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Kim JY; Park HD; Park E; Chon JW; Park YK Ann N Y Acad Sci; 2009 Aug; 1171():190-5. PubMed ID: 19723055 [TBL] [Abstract][Full Text] [Related]
19. Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism. Grossmann ME; Mizuno NK; Dammen ML; Schuster T; Ray A; Cleary MP Cancer Prev Res (Phila); 2009 Oct; 2(10):879-86. PubMed ID: 19789297 [TBL] [Abstract][Full Text] [Related]
20. Oxidized Products of α-Linolenic Acid Negatively Regulate Cellular Survival and Motility of Breast Cancer Cells. Gutierrez-Pajares JL; Ben Hassen C; Oger C; Galano JM; Durand T; Frank PG Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]